AndrusL., SzaboP., GradyR.W., HanauskeA.R., Huima-ByronT., SlowinskaB., et al. (1998). Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1). Biochem Pharmacol, 55, 1807–1818.
2.
BenneR., and HersheyJ.W. (1978). The mechanism of action of protein synthesis initiation factors from rabbit reticulocytes. J Biol Chem, 253, 3078–3087.
3.
BevecD., JakscheH., OftM., WohlT., HimmelspachM., PacherA., et al. (1996). Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science, 271, 1858–1860.
4.
De ClercqE., and LiG. (2016). Approved antiviral drugs over the past 50 years. Clin Microbiol Rev, 29, 695–747.
5.
DeverT.E., GutierrezE., and ShinB.S. (2014). The hypusine-containing translation factor eIF5A. Crit Rev Biochem Mol Biol, 49, 413–425.
6.
ElfgangC., RosoriusO., HoferL., JakscheH., HauberJ., and BevecD. (1999). Evidence for specific nucleocytoplasmic transport pathways used by leucine-rich nuclear export signals. Proc Natl Acad Sci U S A, 96, 6229–6234.
7.
FujimuraK., ChoiS., WyseM., StrnadelJ., WrightT., and KlemkeR. (2015). Eukaryotic translation initiation factor 5A (EIF5A) regulates pancreatic cancer metastasis by modulating RhoA and Rho-associated kinase (ROCK) protein expression levels. J Biol Chem, 290, 29907–29919.
8.
GutierrezE., ShinB.S., WoolstenhulmeC.J., KimJ.R., SainiP., BuskirkA.R., et al. (2013). eIF5A promotes translation of polyproline motifs. Mol Cell, 51, 35–45.
9.
HartR.A., BillaudJ.N., ChoiS.J., and PhillipsT.R. (2002). Effects of 1,8-diaminooctane on the FIV Rev regulatory system. Virology, 304, 97–104.
10.
HauberI., BevecD., HeukeshovenJ., KratzerF., HornF., ChoidasA., et al. (2005). Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest, 115, 76–85.
11.
HoqueM., Hanauske-AbelH.M., PalumboP., SaxenaD., D'Alliessi GandolfiD., ParkM.H., et al. (2009). Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A. Retrovirology, 6, 90.
12.
ImamS., MirmiraR.G., and JaumeJ.C. (2014). Eukaryotic translation initiation factor 5A inhibition alters physiopathology and immune responses in a “humanized” transgenic mouse model of type 1 diabetes. Am J Physiol Endocrinol Metab, 306, E791–E798.
13.
JakusJ., WolffE.C., ParkM.H., and FolkJ.E. (1993). Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. J Biol Chem, 268, 13151–13159.
14.
KemperW.M., BerryK.W., and MerrickW.C. (1976). Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Balpha and M2Bbeta. J Biol Chem, 251, 5551–5557.
15.
MalimM.H., TileyL.S., McCarnD.F., RuscheJ.R., HauberJ., and CullenB.R. (1990). HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell, 60, 675–683.
16.
MelisN., RuberaI., CougnonM., GiraudS., MograbiB., BelaidA., et al. (2016). Targeting eIF5A hypusination prevents anoxic cell death through mitochondrial silencing and improves kidney transplant outcome. J Am Soc Nephrol [Epub ahead of print]; DOI: 10.1681/ASN.2016010012.
17.
MounceB.C., CesaroT., MoratorioG., HooikaasP.J., YakovlevaA., WernekeS.W., et al. (2016a). Inhibition of polyamine biosynthesis is a broad-spectrum strategy against RNA viruses. J Virol, 90, 9683–9692.
18.
MounceB.C., PoirierE.Z., PassoniG., Simon-LoriereE., CesaroT., ProtM., et al. (2016b). Interferon-induced spermidine-spermine acetyltransferase and polyamine depletion restrict Zika and Chikungunya viruses. Cell Host Microbe, 20, 167–177.
19.
NakanishiS., and ClevelandJ.L. (2016). Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer. Amino Acids, 48, 2353–2362.
20.
OlsenM.E., FiloneC.M., RozelleD., MireC.E., AgansK.N., HensleyL., et al. (2016). Polyamines and hypusination are required for ebolavirus gene expression and replication. mBio, 7, pii: e00882-16.
21.
ParkM.H., CooperH.L., and FolkJ.E. (1981). Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc Natl Acad Sci U S A, 78, 2869–2873.
22.
ParkM.H., JoeY.A., KangK.R., LeeY.B., and WolffE.C. (1996). The polyamine-derived amino acid hypusine: its post-translational formation in eIF-5A and its role in cell proliferation. Amino Acids, 10, 109–121.
23.
RossiD., KuroshuR., ZanelliC.F., and ValentiniS.R. (2014). eIF5A and EF-P: two unique translation factors are now traveling the same road. Wiley Interdiscip Rev RNA, 5, 209–222.
24.
RuhlM., HimmelspachM., BahrG.M., HammerschmidF., JakscheH., WolffB., et al. (1993). Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol, 123, 1309–1320.
25.
SchraderR., YoungC., KozianD., HoffmannR., and LottspeichF. (2006). Temperature-sensitive eIF5A mutant accumulates transcripts targeted to the nonsense-mediated decay pathway. J Biol Chem, 281, 35336–35346.
26.
SchreierM.H., ErniB., and StaehelinT. (1977). Initiation of mammalian protein synthesis. I. Purification and characterization of seven initiation factors. J Mol Biol, 116, 727–753.
27.
SchroederM., KolodzikA., PfaffK., PriyadarshiniP., KrepstakiesM., HauberJ., et al. (2014). In silico design, synthesis, and screening of novel deoxyhypusine synthase inhibitors targeting HIV-1 replication. ChemMedChem, 9, 940–952.
28.
ShenT., and HuangS. (2016). Repositioning the old fungicide ciclopirox for new medical uses. Curr Pharm Des, 22, 4443–4450.
29.
ZukD., and JacobsonA. (1998). A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. EMBO J, 17, 2914–2925.
